The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma: First results from the ETERNITY study (EORTC 1419).
 
Michael Weller
Honoraria - Merck Serono; MSD; Novocure; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck Serono; Orbus Therapeutics; Pfizer; Teva; Tocagen
Research Funding - Bayer (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)
 
Guido Reifenberger
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie
Research Funding - Merck; Roche
 
Emilie Le Rhun
Honoraria - Mundipharma; Novartis
Consulting or Advisory Role - Abbvie; Daiichi Sankyo
Research Funding - Amgen (Inst); Mundipharma (Inst)
 
Jennifer Leigh Clarke
Consulting or Advisory Role - Agios
Research Funding - Agios (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Agios
 
Riccardo Soffietti
Consulting or Advisory Role - Celldex; Roche/Genentech
 
Antje Wick
No Relationships to Disclose
 
Olivier L. Chinot
Honoraria - Abbvie; Bristol-Myers Squibb; Immatics; IPSEN; SERVIER
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Roche
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - Patent with aix Marseille University on the use of mmp as biomarkers to predict the benefit of anti angiogenic agents
Travel, Accommodations, Expenses - SERVIER
 
Francois Ducray
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Novocure
 
Peter Hau
No Relationships to Disclose
 
Kerrie Leanne McDonald
No Relationships to Disclose
 
Christine Marosi
No Relationships to Disclose
 
Oliver Schnell
No Relationships to Disclose
 
Andreas Felix Hottinger
Consulting or Advisory Role - Bristol-Myers Squibb; Karyopharm Therapeutics; Karyopharm Therapeutics; Novocure
Research Funding - Novocure
Travel, Accommodations, Expenses - Celgene
 
Jaap C. Reijneveld
No Relationships to Disclose
 
Giuseppe Lombardi
No Relationships to Disclose
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; AstraZeneca; Deciphera; Genentech/Roche; GW Pharmaceuticals; Immunomic Therapeutics; KIYATEC; Lilly; Puma Biotechnology; Taiho Pharmaceutical; Tocagen; Vascular Biogenics; VBI Vaccines; ZIOPHARM Oncology
Speakers' Bureau - Merck; Prime Oncology
Research Funding - Abbvie (Inst); Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Beigene (Inst); Genentech/Roche (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Vascular Biogenics (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Martin Klein
No Relationships to Disclose
 
Thierry Gorlia
No Relationships to Disclose
 
Joerg Felsberg
No Relationships to Disclose
 
Caroline Hertler
No Relationships to Disclose